Biotech Stocks Have Colds, but They Can Heal
September 13, 2021 at 15:05 PM EDT
This year hasn’t been kind to biotechnology stocks and related exchange traded funds. The headwinds faced by these assets were ratcheted up last week when the Biden administration revealed plans to pursue lower drug prices. As a result, the ALPS Medical Breakthroughs ETF (SBIO) lost 1.81% on...
